Efficacy of CDK9 inhibition in therapy of post-myeloproliferative neoplasm (MPN) secondary (s) AML cells.
Warren C FiskusTaghi ManshouriChristine BirdwellChristopher P MillLucia MasarovaPrithviraj BoseTapan Mahendra KadiaNaval G DaverCourtney D D DiNardoGautam BorthakurJoseph D KhourySrdan VerstovsekKapil N BhallaPublished in: Blood cancer journal (2022)